In fAD caused by mutations in PS1, defective regulation could have physio-pathological implications, resulting in altered intracellular transport of AChE, which has also been demonstrated for other key glycoproteins in AD, such as TREM2 [23] and BACE1 [40]. The gene discussed is PSEN1; the disease is familial Alzheimer disease.